Clinical trial

Prognostic Impact of Diabetes and Weight Variability in Telemonitored Heart Failure

NCT07561866

Drugs and interventions used in this trial

3 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

OTHER · Unmapped registry intervention Diabetes Status Find medicine records · Find other trials using this name

OTHER · Unmapped registry intervention Comorbidity Burden Find medicine records · Find other trials using this name

OTHER · Unmapped registry intervention Weight variability Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Prognostic Impact of Diabetes and Weight Variability in Telemonitored Heart Failure

Design: OBSERVATIONAL · Status: COMPLETED · Phase: Not specified

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeOBSERVATIONAL

Start date2018-09-03

PhaseN/A

Conditions

Chronic Heart Failureunresolved

Type 2 Diabetesverified · MONDO: type 2 diabetes mellitus

Diabetes (DM)unresolved

Interventions

Diabetes StatusOTHER

Comorbidity BurdenOTHER

Weight variabilityOTHER

Sponsors & collaborators

Satelialead sponsor

Mapped research locations

BordeauxFrance1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07561866 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.